• 1. The suppression of metastatic lung cancer by pulmonary administration of polymer nanoparticles for co-delivery of doxorubicin and Survivin siRNA
  Caina Xu,Huayu Tian,Ping Wang,Yanbing Wang,Xuesi Chen Biomater. Sci. 2016 4 1646
• 2. Nanotechnology lights up the antitumor potency by combining chemotherapy with siRNA
  Jian Sun,Edikan Archibong Ogunnaike,Xing Jiang,Zhaowei Chen J. Mater. Chem. B 2021 9 7302
• 3. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy
  Shiyang Shen,Meng Liu,Teng Li,Shiqi Lin,Ran Mo Biomater. Sci. 2017 5 1367
• 4. Doxorubicin-conjugated β-NaYF4:Gd3+/Tb3+ multifunctional, phosphor nanorods: a multi-modal, luminescent, magnetic probe for simultaneous optical and magnetic resonance imaging and an excellent pH-triggered anti-cancer drug delivery nanovehicle
  Preeti Padhye,Aftab Alam,Suvankar Ghorai,Samit Chattopadhyay,Pankaj Poddar Nanoscale 2015 7 19501
• 5. Design of tumor-homing and pH-responsive polypeptide–doxorubicin nanoparticles with enhanced anticancer efficacy and reduced side effects
  Jin Hu,Lining Xie,Wenguo Zhao,Mengmeng Sun,Xinyu Liu,Weiping Gao Chem. Commun. 2015 51 11405

Introduction to 3-Maleimidopropionic acid hydrazide (CAS No. 359436-60-5)

3-Maleimidopropionic acid hydrazide (CAS No. 359436-60-5) is a specialized organic compound that has garnered significant attention in the field of biochemical research and pharmaceutical development. This compound, characterized by its maleimide and hydrazide functional groups, exhibits unique chemical properties that make it a valuable tool in various molecular interactions, particularly in the context of protein labeling and cross-linking applications. The maleimide moiety, known for its high reactivity with thiol groups, and the hydrazide group, which can participate in Schiff base formation, contribute to its versatility in synthetic chemistry and biotechnology.

The utility of 3-maleimidopropionic acid hydrazide has been extensively explored in the development of probes and reagents for biochemical studies. Its ability to form stable covalent bonds with biomolecules has made it indispensable in techniques such as immunofluorescence labeling, where it is used to conjugate antibodies or other proteins with fluorophores for high-resolution imaging. Additionally, this compound plays a crucial role in the construction of biosensors and diagnostic tools, where its reactivity allows for the precise modification of surface molecules.

In recent years, advancements in drug discovery have highlighted the importance of 3-maleimidopropionic acid hydrazide as a building block for novel therapeutic agents. The compound's bifunctional nature enables the creation of conjugates that can simultaneously target multiple biological pathways or enhance drug delivery systems. For instance, researchers have leveraged its reactivity to develop targeted drug delivery vehicles that exploit the specific binding properties of maleimide groups to receptors overexpressed in tumor cells. This approach has shown promise in preclinical studies for improving the efficacy of chemotherapeutic agents while reducing systemic toxicity.

The hydrazide group in 3-maleimidopropionic acid hydrazide also contributes to its broad applicability. Hydrazides are known for their ability to undergo condensation reactions with carbonyl compounds, forming stable Schiff bases. This reaction mechanism has been utilized to create novel ligands for metal ions, which are essential in various catalytic processes and have potential applications in medicinal chemistry. For example, studies have demonstrated the use of derivatives of 3-maleimidopropionic acid hydrazide in designing metal-organic frameworks (MOFs) that exhibit enhanced selectivity and stability for small molecule binding.

Recent research has also explored the role of 3-maleimidopropionic acid hydrazide in modulating protein-protein interactions (PPIs). By incorporating this compound into designed peptides or proteins, scientists can investigate the dynamics of cellular signaling pathways with greater precision. The maleimide group serves as a handle for site-specific labeling, while the hydrazide moiety allows for further chemical modifications if needed. Such tools are invaluable in understanding complex biological networks and have implications for developing targeted therapies against diseases like cancer and neurodegenerative disorders.

The synthesis of 3-maleimidopropionic acid hydrazide typically involves multi-step organic transformations that require careful optimization to ensure high yield and purity. Key steps often include the formation of the maleimide ring through cyclization reactions and subsequent functionalization with a hydrazide group. Advances in synthetic methodologies have enabled more efficient routes to this compound, making it more accessible for industrial applications. Furthermore, green chemistry principles have been increasingly integrated into its synthesis to minimize environmental impact.

The safety profile of 3-maleimidopropionic acid hydrazide is another critical consideration in its application. While not classified as a hazardous material under standard regulatory guidelines, proper handling procedures must be followed to prevent unintended exposure. Personal protective equipment (PPE) such as gloves and lab coats is recommended during handling, and work should be conducted in well-ventilated areas or under fume hoods to ensure safety.

In conclusion, 3-maleimidopropionic acid hydrazide (CAS No. 359436-60-5) is a multifaceted compound with significant potential across multiple domains of biochemical research and pharmaceutical development. Its unique structural features enable diverse applications ranging from protein labeling to drug delivery systems, making it an indispensable tool for scientists working at the intersection of chemistry and biology. As research continues to uncover new ways to harness its properties, the utility of this compound is expected to expand further into uncharted territories of molecular science.

• 820247-10-7(1H-Pyrrole-1-propanamide, N-(2-aminoethyl)-2,5-dihydro-2,5-dioxo-)
• 5135-54-6(1-(3-dimethylaminopropyl)-1h-pyrrole-2,5-dione)
• 28537-69-1(1H-Pyrrole-2,5-dione,1,1'-(1,3-propanediyl)bis-)
• 175290-73-0(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide hydrochloride)
• 181148-01-6(4-Maleimidobutyric acid hydrazide)
• 359436-62-7(11-Maleimidoundecanoic Acid Hydrazide)
• 1286754-17-3(5-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentanehydrazide)
• 110008-26-9(1H-Pyrrole-2,5-dione, 1-[3-[(3-aminopropyl)amino]propyl]-)
• 81186-33-6(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide)
• 110008-25-8(1-(3-Aminopropyl)-2,5-dihydro-1H-pyrrole-2,5-dione)